Forward Pharma A/S (FWPAY)
OTCMKTS: FWPAY · Delayed Price · USD
2.80
0.00 (0.00%)
May 22, 2023, 4:00 PM EDT - Market closed
Company Description
Forward Pharma A/S does not have significant operations.
Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications.
Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Forward Pharma A/S
| Country | Denmark |
| Founded | 2005 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Claus Svendsen |
Contact Details
Address:
120 Broadway, 32nd Floor New York, New York 10271 United States | |
| Phone | 2122383128 |
Stock Details
| Ticker Symbol | FWPAY |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001712786 |
| SIC Code | 8880 |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 26, 2019 | 424B3 | Prospectus |
| Sep 11, 2017 | 424B3 | Prospectus |
| Aug 3, 2017 | 424B3 | Prospectus |